Institutional governance · live ledger
Operational Governance
Continuous oversight across editorial, peer-review, statistical, regulatory, pharmacovigilance and AI-synthesis workflows. Every action is timestamped, attributable and traceable to a named reviewer or governed system.
SLA · triage 18h
Decision · 21d median
Acceptance · 34%
Active manuscripts
47
In peer review
18
Statistical review
6
Medical review
11
Production
7
Published YTD
312
Editorial queue · live
- MS-2026-0418medical review expeditedGLP-1 receptor agonists in HFpEF: pooled analysis2 reviewers · 3d in stage
- MS-2026-0423peer reviewWastewater SARS-CoV-2 nowcasting in West Africa2 reviewers · 1d in stage
- MS-2026-0411stats review urgentPediatric sepsis bundles: cluster-randomized trial3 reviewers · 5d in stage
- MS-2026-0399productionAntimicrobial stewardship in Lagos tertiary care2 reviewers · 8d in stage
- MS-2026-0404triageMaternal anemia in low-resource settings: living review0 reviewers · 6h in stage
- MS-2026-0387indexing expeditedTuberculosis MDR genomic surveillance pipeline2 reviewers · 12d in stage
Workflow stream
- 11:42 · peer-reviewProf. Lin Wei approved revision MS-2026-0418 · GLP-1 in HFpEF
- 10:58 · pharmacovigilanceSignal Engine escalated cluster Semaglutide · pancreatitis (n=41)
- 10:21 · outbreakEpi Watch stage advanced → containment Cholera · Lagos cluster #C-2026-07
- 09:47 · regulatoryDr. A. Diallo flagged label change EMA · empagliflozin renal warning
- 09:12 · aiTICH-Synthesis v4.2 re-synthesized evidence Article · Type 2 diabetes management
- 08:34 · editorialH. Martín assigned reviewers (2) MS-2026-0423 · Wastewater nowcasting
- 07:55 · peer-reviewDr. E. Park submitted review MS-2026-0411 · Pediatric sepsis
- 07:12 · aiRetraction Watch Bot verified citation integrity 188 articles scanned · 0 retractions
Clinical Governance Board
84 reviewers · 6 divisions
Verifies medical accuracy, GRADE evidence levels and bedside applicability.
Regulatory Affairs Council
21 advisors · WHO/FDA/EMA liaisons
Tracks label changes, advisories, and emergency-use authorizations across jurisdictions.
Pharmacovigilance Unit
Signal engine · 24/7
Continuous ADR clustering, disproportionality analysis and escalation to regulatory partners.